Expert assistance ensures clear, concise, comprehensive dossiers

AMCP formulary dossiers provide a comprehensive collection of US clinical and economic evidence for new and existing medical drugs, tests, or devices. They have been widely adopted as the industry standard for the synthesis and organization of clinical, safety, and economic data, and are used to help managed care organizations and health care decision-makers make formulary and medical policy considerations regarding coverage or reimbursement.

Dossiers present the most recent, relevant, scientifically accurate and balanced information regarding pharmaceutical products, including background information on the product and the disease states it is used for, current clinical evidence, plus an economic value and model report; however, they must not contain any material that could be construed as promotional. Approved dossiers may be reviewed and updated when there are significant changes regarding the pharmaceutical product, such as changes to the prescribing information (e.g., indication, dosing), new clinical or economic evidence, new safety information, identification of patients or subpopulations who should or should not receive the product, and demonstrations of real-world or long-term effectiveness. Given the amount and complexity of information in these documents, they are often lengthy documents, and are understandably time consuming to create and maintain.

Med Communications understands the importance of communicating your product’s value effectively in order to facilitate formulary additions and optimize reimbursement. We have partnered with several clients and successfully developed valuable and strategic product dossiers across various therapeutic areas. We often emphasize our team’s education and expertise when describing our services, but in the context of dossier writing, these qualities truly shine. Consider this feedback we received about one of our writers:

“I wanted to provide you with feedback on a Med Communications medical writer. Since she’s started, I’ve worked with her on standard response documents, medical information requests, and medical affairs materials. When she started, I was immediately impressed with the logic she applied to standard response content and medical information responses. She was a natural and I partly attributed that to clinical experience. As I worked with her on the update of the AMCP dossier, it was clear that she also had a strategic lens and was able to discern critical inclusions as well as practical solutions to lead and complete the update with as little impact to the team (time) as possible. She seems to naturally filter out unnecessary information, which is a skill that I have seen just about all new people struggle with, but it seems to come more naturally to her. More recently I have worked with her on a couple writing assets and I continue to be impressed. Without my prompting, she picked up on errors and improvements that even other seasoned writers would not pick up on. She not only has a keen attention to detail, but she also applies literal thinking to ensure proper interpretation of claims and statements. I’ve worked with and directly mentored many writers over the 20 years I’ve been here, and she is one of the finest. She jumps right into new things and isn’t afraid to try things on her own, speak up, disagree, and offer suggestions. I love working with her!”
–Top 10 Pharma Company, Scientific Communications, Long-Term Client of Over 15 Years

A project as complex and critical as a dossier is too important to risk entrusting to anyone but an expert. For more than 25 years, Med Communications has provided the expertise you need. To request a capabilities presentation, contact us: 877-477-0977 or https://medcommunications.com/contact-us.